A Pharma-Fueled Effort At Spot Television


It’s now approved for the treatment of moderate to severe eczema; ulcerative colitis; and ankylosing spondylitis. It’s already used for rheumatoid and psoriatic arthritis.

Informing consumers about its potential benefits has taken this pharmaceutical brand to viewers via a new Spot TV campaign — one that tops the latest Media Monitors report.

Please Login to view this premium content. (Not a member? Join Today!)